Yes, the mind does boggle. Some better with riba--some without--Some better with larger doses or treatment time--some without. Guess that is why they are trials. But they do have impressive SVR rates in general. And we really don't know why the variables. Just hope all of us in trials now are in the 100% SVR group.
SuziQ
Loopy Lisa said
Nov 19, 2013
I was shocked to see that Hep B had a much higher death rate considering that only 15% become chronic. Awfully high death rates for both B and C considering there has been treatment for years! :(
I have a poor region strain, yay! lol!
lauralou57 said
Nov 18, 2013
My hep C doc presented at the meeting so I went in and tried to read everything I could possibly begin to understand.
I agree with you..the mind boggles!
mallani said
Nov 18, 2013
Hi guys,
This is a summary of most abstracts presented at the recent Liver Meeting. The mind boggles.
Thanks Malcolm.
Yes, the mind does boggle. Some better with riba--some without--Some better with larger doses or treatment time--some without. Guess that is why they are trials. But they do have impressive SVR rates in general. And we really don't know why the variables. Just hope all of us in trials now are in the 100% SVR group.
SuziQ
I was shocked to see that Hep B had a much higher death rate considering that only 15% become chronic. Awfully high death rates for both B and C considering there has been treatment for years! :(
I have a poor region strain, yay! lol!
My hep C doc presented at the meeting so I went in and tried to read everything I could possibly begin to understand.
I agree with you..the mind boggles!
Hi guys,
This is a summary of most abstracts presented at the recent Liver Meeting. The mind boggles.
http://www.natap.org/2013/AASLD/AASLD_40.htm